Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kathy Hibbs Insider Profile
11 Followers
Kathy Hibbs, SVP & GC at Genomic Health, holds 43.13K shares in Standard BioTools (Ticker: LAB), holds 1.22M shares in 23andMe Holding (Ticker: ME), holds 15.79K shares in Genomic Health (Ticker: GHDX).
Kathy Hibbs Genomic Health (GHDX)SVP & GC
Genomic Health (GHDX)
SVP & GC
Not Ranked
Kathy Hibbs has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Kathy Hibbs
Kathy Hibbs's Trading History
Genomic Health
Feb 19, 2014
―
Uninformative Sell
36.58K
$1.00M
23andMe Holding
May 21, 2024
CAO
Uninformative Sell
19.05K
$537.93K
SomaLogic
―
―
―
―
Standard BioTools
Jul 02, 2024
Director
Uninformative Buy
―
$94.45K
List of latest transactions for each holding click on a transaction to see Kathy Hibbs's performance on stock
You May Also Like
Kathy Hibbs insider profile FAQ
What is the percentage of profitable transactions made by Kathy Hibbs?
The percentage of profitable transactions made by Kathy Hibbs is ―.
What is the average return per transaction made by Kathy Hibbs?
The average return per transaction made by Kathy Hibbs is ―.
What stocks does Kathy Hibbs hold?
Kathy Hibbs holds: GHDX, ME, SLGC, LAB stocks.
What was Kathy Hibbs’s latest transaction?
Kathy Hibbs latest transaction was an Uninformative Buy of ―.
What was Kathy Hibbs's most profitable transaction?
Kathy Hibbs’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kathy Hibbs's role in Genomic Health?
Kathy Hibbs's role in Genomic Health is SVP & GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.